Synergistic combination of perphenazine and temozolomide suppresses patient-derived glioblastoma tumorspheres
The synergistic combination of PER and TMZ has potential as a novel combination treatment strategy for GBM.
Authors
- Jong Hee Chang (ORCID: https://orcid.org/0000-0003-1509-9800)
- Hye Joung Cho
- Eui Hyun Kim (ORCID: https://orcid.org/0000-0002-2523-7122)
- Hun Ho Park (ORCID: https://orcid.org/0000-0002-2526-9693)
- Wan‐Yee Teo (ORCID: https://orcid.org/0000-0002-1046-1674)
- Ju Hyung Moon (ORCID: https://orcid.org/0000-0002-8925-5821)
- Kibyeong Kim (ORCID: https://orcid.org/0000-0003-4207-9864)
- Nam Hwa Kim
- Seok‐Gu Kang (ORCID: https://orcid.org/0000-0001-5676-2037)
- Seungsoo Chung (ORCID: https://orcid.org/0000-0002-3119-9628)
- Ran Joo Choi (ORCID: https://orcid.org/0000-0001-5024-8221)
- Jun Hong (ORCID: https://orcid.org/0009-0005-2079-0489)
- Ryong Nam Kim
- Sohyun Kim (ORCID: https://orcid.org/0000-0003-0820-3411)
- Jin‐Kyoung Shim (ORCID: https://orcid.org/0000-0003-3819-0180)
- Seo Jin Kim (ORCID: https://orcid.org/0000-0002-3641-1616)
Institutions
- Agency for Science, Technology and Research (SG)
- Yonsei University (KR)
- Severance Hospital (KR)
- Duke-NUS Medical School (SG)
- Institute of Molecular and Cell Biology (SG)
Publication Details
- Journal
- Neuro-Oncology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1093/neuonc/noae211
- Citations
- 10
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.38
Funders
- Korea Health Industry Development Institute
- National Research Foundation of Korea
- Yonsei University College of Medicine